<--- Back to Details
First PageDocument Content
Myeloid leukemia / Acute leukemia / Acute myeloid leukemia / Leukemia / Acute lymphoblastic leukemia / B-cell chronic lymphocytic leukemia / Childhood leukemia / Hairy cell leukemia / Juvenile myelomonocytic leukemia / Oncology / Medicine / Lymphocytic leukemia
Date: 2008-08-29 13:48:57
Myeloid leukemia
Acute leukemia
Acute myeloid leukemia
Leukemia
Acute lymphoblastic leukemia
B-cell chronic lymphocytic leukemia
Childhood leukemia
Hairy cell leukemia
Juvenile myelomonocytic leukemia
Oncology
Medicine
Lymphocytic leukemia

Add to Reading List

Source URL: seer.cancer.gov

Download Document from Source Website

Share Document on Facebook

Similar Documents

MDACC LEUKEMIA AND LYMPHOMA Europe and the USA Linking Knowledge and Practice

DocID: 1vhjk - View Document

Genome-wide mapping of proviral integration sites in aggresive virus-induced leukemia Nicolas Rosewick1,2, Vincent Hahaut1, Maria Artesi1, Keith Durkin1, Ambroise Marçais3, Philip Griebel4, Natasa Arsic4, Véronique Ave

DocID: 1vcJH - View Document

Boswellic acid acetate induces apoptosis through caspase-mediated pathways in myeloid leukemia cells Lijuan Xia, Duo Chen, Rui Han, et al. Mol Cancer Ther 2005;4:Updated version

DocID: 1v6bB - View Document

The Dual E-selectin/CXCR4 Antagonist GMI-1359 Exerts Anti-leukemia Efficacy Against FLT3-ITDmutated Acute Myeloid Leukemia in A Patient-derived Xenograft Murine Model Mouse-1 Mouse-2

DocID: 1uSbg - View Document

A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan

DocID: 1uJQ2 - View Document